Dr. Andrés Finzi from the Université de Montréal and Dr. Renée Bazin from Héma-Québec and their teams recently describe a novel high-throughput method to track levels of antibodies made against SARS-CoV-2 spike protein in the plasma of donors that recovered from COVID-19 in a recent issue of Transfusion.